Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
Clinical trial NCT01500278 · COMPLETED
Trial details
- NCT number
- NCT01500278
- Sponsor
- UCB Pharma SA
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2015-11-01
- Enrollment
- 915
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.